AMP Capital Investors’s AngioDynamics ANGO Stock Holding History

AMP Capital Investors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,800	Closed	-$188K	–	1142
2019 Q4	$188K	Buy	+11,800	New	+$180K	﹤0.01%	1145

Other funds holding ANGO

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

AMP Capital Investors's ANGO Position: Q1 2020 in Review

AMP Capital Investors sold out of AngioDynamics (ANGO) in Q1 2020, closing a stake of 11,800 shares — an estimated $188K sold.

AMP Capital Investors first reported a position in ANGO in Q4 2019 and held it in 1 quarter. The position peaked at $188K in Q4 2019. 158 funds tracked by Wall St. Rank hold ANGO as of Q1 2020.

AMP Capital Investors reported no remaining AngioDynamics position as of Q1 2020 after selling out during the quarter.
AMP Capital Investors sold 11,800 AngioDynamics shares in Q1 2020, an estimated $188K.
AMP Capital Investors first reported a position in AngioDynamics in Q4 2019 and held it in 1 quarter.
AMP Capital Investors's AngioDynamics position peaked at $188K in Q4 2019.
158 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2020.

Based on AMP Capital Investors's 13F filing for Q1 2020, filed 13 May 2020.